AQR Capital Management
GMAB icon

AQR Capital Management’s Genmab GMAB Stock Holding History

AQR Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23M Buy
83,279
+1,052
+1% +$31.5K ﹤0.01% 2273
2025
Q4 		$2.53M Buy
82,227
+8,526
+12% +$266K ﹤0.01% 1987
2025
Q3 		$2.26M Buy
73,701
+43,738
+146% +$1.07M ﹤0.01% 1906
2025
Q2 		$619K Buy
+29,963
New +$615K ﹤0.01% 2486

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AQR Capital Management's GMAB Position: Q1 2026 in Review

AQR Capital Management increased its Genmab (GMAB) stake by 1.3% in Q1 2026, buying an estimated $31.5K and bringing the position to 83,279 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2273.

AQR Capital Management first reported a position in GMAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.53M in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • AQR Capital Management held 83,279 shares of Genmab worth $2.23M as of Q1 2026.
  • AQR Capital Management bought 1,052 Genmab shares in Q1 2026, an estimated $31.5K.
  • Genmab made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2273 holding.
  • AQR Capital Management first reported a position in Genmab in Q2 2025 and has held it in 4 quarters since.
  • AQR Capital Management's Genmab position peaked at $2.53M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.